Proton therapy, a type of external beam radiation therapy, is a safe and effective treatment for prostate cancer, according to two new studies.
In the first study, researchers at the University of Florida in Jacksonville, Fla., prospectively studied 211 men with low-, intermediate-, and high-risk prostate cancer. The men were treated with proton therapy, a specialised type of external beam radiation therapy that uses protons instead of X-rays. After a two year follow-up, the research team led by Nancy Mendenhall, MD, of the University of Florida Proton Therapy Institute, reported that the treatment was effective and that the gastrointestinal and genitourinary side effects were generally minimal.
‘This study is important because it will help set normal tissue guidelines in future trials,’ Dr. Mendenhall, said.
In the second study, researchers from Massachusetts General Hospital in Boston, Loma Linda University Medical Center in Loma Linda, Calif., and the Radiation Therapy Oncology Group in Philadelphia performed a case-matched analysis comparing high-dose external beam radiation therapy using a combination of photons (X-rays) and protons with brachytherapy (radioactive seed implants).
Over three years, 196 patients received the external beam treatments. Their data was compared to 203 men of similar stages who received brachytherapy over the same time period. Researchers then compared the biochemical failure rates (a statistical measure of whether the cancer relapses) and determined that men who received the proton/photon therapy had the same rate of recurrence as the men who received brachytherapy.
‘For men with prostate cancer, brachytherapy and external beam radiation therapy using photons and protons are both highly effective treatments with similar relapse rates,’ John J. Coen, MD, a radiation oncologist at Massachusetts General Hospital in Boston, said. ‘Based on this data, it is our belief that men with prostate cancer can reasonably choose either treatment for localised prostate cancer based on their own concerns about quality of life without fearing they are compromising their chance for a cure.’ EurekAlert

Children and young adults scanned multiple times by computed tomography (CT) have a small increased risk of leukaemia and brain tumours in the decade following their first scan.
The findings from a study of more than 175,000 children and young adults was led by researchers at Newcastle University and at the National Cancer Institute, part of the National Institutes of Health, USA.
The researchers emphasise that when a child suffers a major head injury or develops a life-threatening illness, the benefits of clinically appropriate CT scans should outweigh future cancer risks.
Lead author Dr Mark Pearce, Reader in Lifecourse Epidemiology at Newcastle University said: ‘CT scans are accurate and fast so they should be used when their immediate benefits outweigh the long-term risks. However, now we have shown that CT scans increase the risk of cancer, we must ensure that when they are used they are fully justified from a clinical perspective.’
The study represents the culmination of almost two decades of research in this area at Newcastle University, and is jointly funded by the UK Department of Health and NCI/NIH.
CT imaging is a vital and commonly used diagnostic technique and it is used more frequently in countries such as the USA and Japan. However, CT scans deliver a dose of ionising radiation to the body part being scanned and to nearby tissues. Even at relatively low doses, ionising radiation can break the chemical bonds in DNA, causing damage to genes that may increase a person